Nevertheless, it is particularly important to note that the presence of Ankyloblepharon Filiforme Adnatum should serve as a pointer for a complete evaluation (including physical health exams and family medical history assessment) to exclude any associated congenital abnormalities in the newborn child.
Ankyloblepharon Filiforme Adnatum is seen along-with a host of syndromes and conditions such as:
It is important to note that having a risk factor does not mean that one will get the condition. A risk factor increases one’s chances of getting a condition compared to an individual without the risk factors. Some risk factors are more important than others.
Also, not having a risk factor does not mean that an individual will not get the condition. It is always important to discuss the effect of risk factors with your healthcare provider.
Ankyloblepharon Filiforme Adnatum (AFA) is an eye condition in which the upper and lower eyelids are partially and irregularly fused along their margins.
Ankyloblepharon Filiforme Adnatum usually occurs in isolation (sporadic), but sometimes may form part of a syndrome. Thus, AFA may serve as an early indicator of other systemic abnormalities in the baby that calls for further investigation.
In Ankyloblepharon Filiforme Adnatum (AFA), no significant eye signs and symptoms are noted apart from compromised vision, unless the condition forms part of a syndrome. The signs and symptoms include:
Additional signs and symptoms of the underlying/associated condition, if any, may be noted.
In AFA, the extreme corners of the eyelids are usually spared; the strands are not present on the periphery. The strands are seen to originate from behind the eyelashes on the upper and lower eyelids.
Typically, Ankyloblepharon Filiforme Adnatum may indicate the presence of other systemic conditions, which may need to be investigated. The following observations and tests may be undertaken by the healthcare provider:
Many clinical conditions may have similar signs and symptoms. Your healthcare provider may perform additional tests to rule out other clinical conditions to arrive at a definitive diagnosis.
The lack of early treatment of Ankyloblepharon Filiforme Adnatum may result in complications due to atrophy from lack of usage of the eye. The complications may include:
Children with underlying/associated conditions may present additional complications.
Currently, it is not possible to prevent Ankyloblepharon Filiforme Adnatum in many cases. However, the following factors may be considered to lower one’s risk for the same:
Please visit our Eye & Vision Health Center for more physician-approved health information:
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.